Cover Image

Glycemic control in diabetic patients treated with Sitagliptin in a single tertiary centre

Background Sitagliptin is a DPP-IV inhibitor and has been proven to reduce HbA1c by 0.8% when used as monotherapy and up to 2.1% when used in combination with maximum dose of metformin. Objectives To evaluate the glycemic control in patients treated with sitagliptin either as monotherapy or as...

Full description

Saved in:
Bibliographic Details
Main Authors: WS, Wan Juani, M., Azura Dina, S., Norlela, M., Norlaila, AW, Norasyikin, O, Ahmad Marzuki, R, Subashini, Loh, Huai Heng, Shahar, Mohammad Arif, O, Mohd Rahman, K., Nor Azmi
Format: Article
Language:English
Published: Malaysian Endocrine and Metabolic Society 2014
Subjects:
R Medicine (General)
RC Internal medicine
Online Access:http://irep.iium.edu.my/50065/4/OP-37.pdf
http://irep.iium.edu.my/50065/
http://www.jmems.org/index.php/jmems/issue/view/5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://irep.iium.edu.my/50065/4/OP-37.pdf
http://irep.iium.edu.my/50065/
http://www.jmems.org/index.php/jmems/issue/view/5

Similar Items